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Background: The detailed pathological phenotype of diet-responsive chronic enteropathy (CE) and its modulation with
dietary therapy remain poorly characterized.
Hypothesis/Objectives: Key mucosal lesions of diet-responsive CE resolve with dietary therapy.
Methods: This was a prospective observational study of 20 dogs with diet-responsive CE. Endoscopic duodenal
biopsies collected before and 6 weeks after the start of a dietary trial were assessed by means of qualitative and quantita-
tive histopathological, immunohistochemical, and ultrastructural criteria. Control duodenal biopsies were obtained from
10 healthy Beagle dogs on 1 occasion.
Results: Compared with control dogs, the CE dogs had higher villus stunting scores and higher overall WSAVA scores, a
lower villus height-to-width ratio, and higher lamina propria density of eosinophils. The CE dogs also had ultrastructural
lesions of the mitochondria and brush border. In common with other studies in which the disease and control populations are
not matched for breed, age, sex, and environment, these comparisons should be interpreted with caution. Comparing biopsies
collected at presentation and 6 weeks after starting the dietary trial, mean lamina propria mononuclear cell score and lamina
propria densities of eosinophils and mononuclear cells decreased. Dietary therapy also improved ultrastructural lesions of the
mitochondria and brush border, eliciting a decrease in intermicrovillar space and an increase in microvillus height.
Conclusions and Clinical Importance: In dogs with diet-responsive CE, the remission of clinical signs with dietary
therapy is associated with subtle decreases in lamina propria density of eosinophils and mononuclear cells, and resolution
of ultrastructural lesions of the enterocyte.
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Idiopathic inflammatory bowel disease (IBD) is acomplex disorder that is thought to involve defective
epithelial barrier function and mucosal tolerance,
coupled with imbalances in the intestinal microbial
flora.1,2 Although IBD is a common diagnosis in dogs
with chronic gastrointestinal signs, pathogenesis of the
disorder in this species is poorly understood.3 Clinical
response to dietary manipulation or antibiotic treat-
ment in some dogs has prompted the emergence of
descriptors such as “diet-responsive enteropathy”4 and
“antibiotic-responsive diarrhea”,5 reflecting the relative
importance of dietary factors and dysbiosis to the
pathogenesis of the disease in specific dogs. Some gast-
roenterologists reserve the term “IBD” for dogs requir-
ing immunosuppressive treatment to achieve clinical
remission, when dietary and antibiotic trials have
failed. Regardless of the clinical terms used to describe
this spectrum of disorders, they have all previously
been characterized by the presence of variable degrees
of intestinal inflammation and may be identified by the
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generic label “chronic enteropathy” (CE).6–9 However,
increasing recognition of the uncertainties of histo-
pathological identification of mucosal inflammation3,10
and the apparent discordance between clinical presen-
tation and severity of inflammation11 have prompted
the generation of a standardized histopathological
scoring system accommodating both inflammatory and
morphological observations under the auspices of the
World Small Animal Veterinary Association (WSA-
VA).12 One of the conundrums of the field has been
the apparent lack of resolution of duodenal histopath-
ological lesions, examined either by qualitative or
quantitative criteria, with clinical remission of CE.13–15
We have re-visited this phenomenon in this study by
means of a comprehensive survey of inflammatory and
morphological duodenal lesions in a cohort of dogs
with diet-responsive CE, assessed by means of the
WSAVA scoring system and a number of quantitative
criteria at both the light and electron microscopic
level.
Materials and Methods
Clinical Cases and Controls
Twenty-nine dogs with gastrointestinal signs of at least
4 weeks’ duration were recruited into this study by the Small
Animal Internal Medicine Service of the Queen Mother Hospital
for Animals (QMHA) at the Royal Veterinary College (RVC)
between March 2007 and July 2008; all dogs were at least 8.0 kg
in body weight at the time of presentation. The study was
approved by the RVC Ethics and Welfare Committee, and
written informed consent was sought before recruitment of all
cases. Of the 29 dogs initially recruited, 20 dogs completed the
6-week study and are described in this manuscript, whereas the
remaining 9 were withdrawn because of deterioration in clinical
signs requiring immunosuppressive treatment (2), discovery or
development of comorbidities (immune-mediated disease, 2; neo-
plastic pulmonary lesions, 1; cardiac arrhythmia, 1), intractability
of the patient (1), and failure of the owner to present the dog for
follow-up evaluation (2). All dogs underwent a thorough diag-
nostic evaluation (including a CBC, serum biochemical profile,
routine urinalysis of a voided sample, fecal flotation, abdominal
ultrasound examination by a board-certified radiologist, assays
for serum trypsin-like immunoreactivity [TLI] and canine pancre-
atic-specific lipase immunoreactivity [cPLI], serum folate and
cobalamin concentrations, and an ACTH stimulation test) to rule
out the underlying structural, metabolic, endocrine, neoplastic,
infectious, and autoimmune disease. The administration of
corticosteroids within 4 weeks of presentation, the presence of
panhypoproteinemia, or the necessity for extended hospitalization
or immunosuppressive treatment, prompted by the presence of
systemic ill health or rapid deterioration of clinical signs, all were
considered exclusion criteria. Videoendoscopy of the stomach,
duodenum, and colon was performed in every dog after with-
holding food for 36–48 hours and preparation with an osmotic
laxative and 2 warm-water enemas. At the time of procurement
of biopsies for this study, ileoscopy was not routinely performed
in every dog by all study endoscopists in the QMHA. Using stan-
dard nonserrated forceps, at least 10 endoscopic biopsy samples
deemed to be of adequate quality (ie, clearly visible villi with dis-
cernible depth of mucosa) were harvested from the cranial duode-
nal flexure and at least 4 biopsy samples were collected from
each of 4 regions of the stomach (pyloric antrum, body, incisura
angularis, and fundus or cardia) and each of the 3 segments of
the colon (ascending, transverse, and descending). This study
reports the results of the duodenal biopsies. Of these, at least 8
were placed into 10% v/v formalin-saline and at least 2 were
placed into glutaraldehyde/paraformaldehyde fixative for electron
microscopy (see below). All biopsy samples were processed within
48 hours after collection. Control tissues comprised endoscopic
biopsies collected from the cranial duodenal flexure of 10 healthy
Beagle dogs immediately after euthanasia, undertaken for reasons
unrelated to this study. The health of these dogs, including fecal
consistency, had been monitored daily, and necropsy examina-
tions performed while harvesting the duodenal biopsies were
unremarkable.
Study Design
This was a prospective observational study of dogs with diet-
responsive CE. Dogs were evaluated at presentation (week 0) and
then 2 and 6 weeks after starting a “hypoallergenic” diet based on
hydrolyzed soy protein.a Serum C-reactive protein (CRP)
concentration was measured and a combined test of intestinal
permeability and absorptive function was performed at each
visit. Gastroduodenoscopy was performed at weeks 0 and 6, after
all other diagnostic tests had been completed. Clinical signs were
assessed by means of the canine chronic enteropathy clinical activ-
ity index (CCECAI)14 on all visits. Dogs were discharged from the
study at week 6, but were subsequently monitored by means of
telephone consultations for periods of at least 6 months.
Intestinal Permeability and Absorptive Function
On the day after presentation (week 0) or the day of presenta-
tion (weeks 2 and 6), a solution containing 10 g/L lactulose (L),
10 g/L D-xylose (X), 10 g/L rhamnose (R), 10 g/L 3-O-D-
methylglucose (G), and 40 g/L sucrose was administered to each
dog by means of an orogastric tube, on each occasion after an
overnight fast. Dogs weighing <10 kg received 100 mL of the
sugar solution, those weighing from 10 to 20 kg received
200 mL, and those weighing >20 kg received 400 mL. Dogs were
allowed free time to urinate in a run before administration of the
sugar solution. Midstream (voided) urine samples were collected
and an aliquot of 10 mL was stored with sodium azide at a final
concentration of 0.1% w/v at 20°C until the time of analysis to
quantitate baseline concentrations of the sugars, which were all
zero or trivial. Dogs were kept in their kennels for 6 hours after
administration of the sugar solution. A midstream urine sample
again was collected at 6 hours, from which an aliquot of 10 mL
was stored with 0.1% w/v sodium azide at 20°C until analysis.
Ultrasound-guided cystocentesis was performed in dogs that did
not urinate. If a dog urinated in the kennel during the 6 hours
after administration of the sugar solution, the test was aborted.
Urinary L/R and X/G ratios were determined by means of gas
chromatography-mass spectrometry at the Gastrointestinal
Laboratory at Texas A&M University using an established
protocol.
Serum C-Reactive Protein
Serum C-reactive protein concentrations were determined by
means of a commercial, previously validated ELISA,b performed
according to the manufacturer’s recommendations.16
Endoscopic Biopsy Evaluation
Light Microscopy. Slides of duodenal biopsies were examined
at low powerc to identify and label all longitudinally sectioned,
well-orientated villi that were associated with, or adjacent to,
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cryptal tissue and subvillous lamina propria. According to the
criteria of Willard et al, none of the biopsies examined in this
study was considered “inadequate” in quality.17 A random num-
ber generator (www.random.org) was used to select 5 “eligible”
villi per dog per visit. By consensus of the study participants, this
number was chosen as a workable compromise between wishing
to capture as much information as possible from the available
biopsy material and the time required for analysis. Cryptal tissue
associated with these villi was assessed in parallel; if the chosen
villi had no or insufficient crypts, the nearest adjacent cryptal tis-
sue on the slide was examined. Evaluation of the chosen villi and
cryptal tissue was both qualitative and quantitative, the former
by means of the WSAVA Standards for the Diagnosis of Gastro-
intestinal Inflammation in Endoscopic Biopsy Samples.12 We
undertook qualitative scoring on the basis of the described
lesions, in which severity was scored as 0 = normal, 1 = mild,
2 = moderate, and 3 = marked for each respective criterion; in
certain instances, lesions were deemed to fall between whole
scores, prompting the use of half scores. All initial histopatholog-
ical assessments for clinical purposes were undertaken by a
board-certified anatomical pathologist (KS). After pilot studies
undertaken by AM and CD under the supervision of the senior
author (OAG) and consultation with KS to ensure consistency of
approach, all qualitative and quantitative data recorded in this
study were collected by OAG by independent assessment of all
biopsies from all dogs to eliminate interobserver variability.
Morphometric Criteria. Quantitative variables in the assess-
ment of duodenal biopsies included (1) villous height—taken as
the distance from the base of the villus to its tip, bisecting the
villus along its length and taking the sum of individual mea-
surements if the villi were not straight in orientation; (2) villous
width—taken as the maximum distance from 1 side of the villus
to the other, measuring perpendicular to the midline of the vil-
lus; (3) numbers of intraepithelial lymphocytes and goblet cells
per 100 enterocytes, counting enterocytes, lymphocytes, and
goblet cells on 1 side of the villus or the other, determined ran-
domly by flipping a coin; and (4) lamina propria areal density
of mononuclear cells, eosinophils, and neutrophils—defining the
region of interest as the middle one-third of the villus, excluding
the central lacteal, muscle fibers, and blood vessels, and count-
ing mononuclear cells indirectly by dividing the total nuclear
area by the mean area of 10 randomly chosen representative
nuclei, and eosinophils and neutrophils directly by identifying
them on the section. A specific macro was designed to enable
areal densities to be calculated by image analysis softwared;
results were expressed as number of cells per 10,000 lm2 of
lamina propria.
Immunohistochemistry. Five well-orientated villi associated
with cryptal tissue were randomly chosen for immunohistochemi-
cal assessments, in a similar manner to those for routine hema-
toxylin and eosin staining. When possible, villi were matched on
the CD3 and IgA slides; if villi could not be paired in this way, a
random number generator (www.random.org) was used to select
unmatched villi in place of the corresponding villi. A routine pro-
tocol for immunohistochemical staining was applied (see Sup-
porting Information). Areal densities of CD3+ and IgA+ cells
were determined in a similar fashion to those for the hematoxylin
and eosin-stained sections, defining the middle third of the villus
and excluding lacteals, muscle fibers, and blood vessels. A specific
macro was developed to enable areal densities to be calculated
based on cytoplasmic staining of positive cells, expressing the
results as numbers of cells per 10,000 lm2 of lamina propria.
Ultrastructural Lesions. Biopsies were processed for electron
microscopy in routine fashion, with fixation in a 2% glutaralde-
hyde and 2% paraformaldehyde solution in sodium cacodylate
buffer, before sequential staining in 1% osmium tetroxide and
2% uranyl acetate. After dehydration, infiltration with resin,
trimming of blocks, preparation of semithin and ultrathin sec-
tions, and counterstaining with lead citrate, the sections were
assessed both qualitatively and quantitatively by transmission
electron microscopy.e A random number generator (www.ran-
dom.org) was used to select 5 well-orientated villi. Randomly
picking 1 side of the villus or the other by flipping a coin, 5 adja-
cent enterocytes from the middle one-third of each villus were
chosen for assessment, measuring 10 microvilli per enterocyte.
Owing to the large volume of data collected in these analyses
(approximately 33,000 data points), measurements were made on
endoscopic biopsies harvested from a random sample of 5 of the
20 study dogs. The assessment protocol was developed in house
by OAG specifically for this study and is described in the Sup-
porting Information. S Miller undertook a pilot study under the
supervision of OAG and S Miah, while AK-T collected all of the
ultrastructural data in this study, verified by independent
measurements on 2 of the same cases by OAG. Qualitative obser-
vations included an assessment of (1) mitochondrial lesions, (2)
microvillar vesiculation, and (3) cytoplasmic vesiculation (scoring
the lesions from 1 [mild] to 3 [severe], 0 being normal); quantita-
tive observations included (1) microvillous height and diameter,
(2) intermicrovillar space, and (3) tight junction width.
Statistical Analyses
The clinical, histopathological, immunohistochemical, and
ultrastructural data at presentation and during the study were
summarized as mean ( standard deviation [SD]) and median
(interquartile range [IQR]). Normality was assessed by visual
inspection of histograms of the data. In the case of the quantita-
tive histopathological measurements of intraepithelial lympho-
cytes per 100 enterocytes, goblet cells per 100 enterocytes, and
CD3+ and IgA+ cells per 10,000 lm2, logarithmic transforma-
tion was undertaken before further statistical analysis.
A linear mixed-effects model was adopted to analyze quantita-
tive clinical variables with time (visit number), accounting for
repeated measures from the same dog. The quantitative histo-
pathological and immunohistochemical data were analyzed in the
same fashion, both at presentation and with visit number. A
generalized linear mixed-effects model was adopted to compare
qualitative histopathological data at presentation and with visit
number, accounting for repeated measures from the same dog
and recoding all of the scores as 0 or 0.5+ for the majority of
variables, owing to the low number of higher scored observa-
tions. In the case of “villous stunting”, “mucosal fibrosis”, and
“lamina propria mononuclear cells”, sufficient higher scored
observations were made to allow recoding in 3 (rather than 2)
groups, namely 1 = scores 0 and 0.5, 2 = scores 1 and 1.5, and
3 = scores 2, 2.5, and 3.
A linear mixed-effects model also was adopted to compare
quantitative ultrastructural data at presentation and with visit
number. Generalized mixed-effects models were used for the cor-
responding qualitative ultrastructural data at presentation and
during the study. Qualitative scores for the 10 microvillous
repeats for each of the enterocytes were identical, and thus only
1 microvillus was used for each enterocyte. “Dog”, “villus within
dog”, and “enterocyte within villus within dog” were considered
as random effects in all models. Likelihood ratio tests were used
to assess significance of effects between nested models. When
appropriate, posthoc analysis was undertaken by Tukey contrasts,
and estimated overall difference between groups or visits was
reported as mean  standard error of the mean (SEM) or, for all
of the qualitative variables other than World Small Animal
Veterinary Association score, odds ratios, and 95% confidence
intervals (95% CI). All analyses were carried out by a statistical
software package.f
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Results
Clinical Cases and Controls
Twenty dogs completed the study, comprising 5
Labrador Retrievers (25% of the study cohort), 2 Staf-
fordshire Bull Terriers (10%), 2 Boxers (10%) and a
single German Shepherd Dog (GSD), West Highland
White Terrier, Border Terrier, Cocker Spaniel, Grey-
hound, Lurcher, Rough Collie, Standard Poodle,
GSD-cross, English Bulldog-cross, and Rottwei-
ler 9 Newfoundland (each 5% of the study cohort).
Of a total of 1,586 dogs presenting to the Internal
Medicine Service of the QMHA over the same time
period, there were 41 Labrador Retrievers (2.6% prev-
alence), 45 Staffordshire Bull Terriers (2.8%), and 73
Boxers (4.6%). Three study dogs were intact males, 6
neutered males, 1 intact female, and 10 neutered
females. Median age at presentation was 3.1 (IQR,
2.1) years, with a range of 0.8 to 10.3 years, whereas
mean ( SD) body weight at presentation was
26.5  11.4 kg, with a range of 8.68 to 50.5 kg. Clini-
cal signs included inappetence (6/20); vomiting (14/20),
sometimes with hematemesis (4/20); small (3/20), large
(1/20), or mixed (13/20) bowel diarrhea; weight loss (3/
20); melena (3/20); and periodic borborygmus and flat-
ulence (2/20), associated with overt abdominal pain in
1 case. Clinical signs had been observed for periods
ranging from 1 month to the lifetime of the dog. A
number of therapies had been administered before
presentation, all without inducing clinical remission,
including a variety of antibiotics (metronidazole [6/20],
cefalexin [1/20], amoxicillin/clavulanate [4/20], enro-
floxacin [2/20], marbofloxacin [1/20], erythromycin
[1/20], and spiramycin [1/20]), H2 blockers (4/20), su-
cralfate (4/20), omeprazole (1/20), metoclopramide
(1/20), sulfasalazine (1/20), ursodiol (1/20), a probiotic
(1/20), kaolin (1/20), and a pancreatic enzyme supple-
ment (1/20). None of the dogs had been exposed to
the hypoallergenic dieta used in the study before
recruitment, but all had undergone some form of
nonspecific dietary manipulation before presentation
without clinical improvement. Median CCECAI at
presentation was 6.5 (4.0), ranging from 3 to 15.
Median serum cPLI concentration at presentation
was 30.0 (53.3) lg/L, ranging from 30 to 362 lg/L.
Two dogs (both Boxers) had results above the refer-
ence limit of 200 lg/L. However, both results were
lower than the commonly accepted threshold of
400 lg/L for the diagnosis of pancreatitis, and both
dogs had unremarkable abdominal ultrasound examin-
ations and showed clinical responses to dietary treat-
ment. Median serum vitamin B12 concentration was
368 (208) ng/L, ranging from 150 to 1,200 ng/L. Only
a single dog had a serum vitamin B12 concentration
below the reference limit of 200 ng/L. Nevertheless,
this animal showed a convincing clinical response to
dietary treatment. Median serum TLI concentration
was 9.0 (5.9) lg/L, ranging from 5.1 to 26.1 lg/L.
Two dogs had serum TLI concentrations just below
the reference limit of 6.0 lg/L, but all serum TLI
concentrations were above 2.5 lg/L and these 2 dogs
showed clinical responses to dietary treatment.
Histopathological, Immunohistochemical, and
Ultrastructural Findings on Presentation
Sixteen of the dogs with CE had mild lymphoplas-
macytic inflammation of the duodenum, in 8 cases
associated with mild eosinophilic infiltrates and in 1
case associated with mild, mixed (eosinophilic/neutro-
philic) infiltrates. One dog had mild-to-moderate lym-
phoplasmacytic inflammation associated with mild,
mixed infiltrates, and 1 dog had moderate-to-marked
plasmacytic inflammation. Additional observations
included mild villous atrophy and increased lympho-
cytic exocytosis across the villous epithelium. The
group of dogs with CE showed more villous stunting
and higher overall WSAVA scores than the healthy
control dogs, but all other individual qualitative lesion
scores showed no significant differences between the
groups (Table 1). Of the quantitative variables, villous
height-to-width ratio was lower and the density of
eosinophils in the lamina propria was higher in the
dogs with CE than in control dogs (Table 2). There
were no significant differences in villous height, counts
of IELs or goblet cells, and densities of mononuclear
cells, neutrophils, CD3+ cells, or IgA+ cells between
the groups (Table 2). Ultrastructural lesions were iden-
tified in the dogs with CE, which showed increased
severity of mitochondrial lesions and cytoplasmic vacu-
olation, increased space between microvilli, and
increased tight junction width at presentation when
compared with the healthy control dogs (Table 3;
Fig 1).
Clinical Findings with Dietary Treatment
The owners of all dogs perceived an improvement in
clinical signs after beginning the hypoallergenic diet.a
Furthermore, all owners chose to continue feeding
their dogs the hypoallergenic diet for at least 6 months
from inception of the study, during which time the
dogs remained asymptomatic or experienced only triv-
ial clinical signs.
Mean body weight increased from weeks 0 to 6
(P = .007) by a 0.87  0.29 kg (Fig 2A). Mean CCE-
CAI decreased from weeks 0 to 2 (P < .0001), but then
showed no significant change from weeks 2 to 6
(P = .44; Fig 2A). Estimated overall decrease in CCE-
CAI was 4.55  0.72 from weeks 0 to 2 and
5.43  0.73 from weeks 0 to 6. Similarly, mean serum
CRP concentration decreased from weeks 0 to 2
(P = .02), but then showed no significant change from
weeks 2 to 6 (P = .98; Fig 2A). However, of 55 serum
samples, only 1 had a CRP concentration above the
upper limit of the reference interval of 7.6 mg/L—an
outlying result of 29.7 mg/L in a single dog on week 0.
Estimated overall decrease in serum CRP concentra-
tion was 3.56  1.33 mg/L from weeks 0 to 2 and
3.79  1.33 mg/L from weeks 0 to 6.
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Mean urinary L/R ratio showed no significant
differences between hospital visits (P = .86; Fig 2B).
Mean urinary X/G ratio increased from weeks 2 to 6
(0.77  0.31; P = .03), but there was no significant
difference in X/G ratio between weeks 0 and 2
(P = .11) or weeks 0 and 6 (P = .87; Fig 2B).
Histopathological, Immunohistochemical, and
Ultrastructural Findings with Dietary Treatment
Of all the qualitative variables assessed by the
WSAVA Standards, only the mean mononuclear cell
score in the lamina propria showed a significant
Table 2. Morphometric and immunohistochemical data at presentation.
Variable Group Mean SD Median IQR Min Max
Estimated Overall
Difference ( SEM) P Value
Villous height (lm) Control 557 89 592 120 325 669 55.1  34.9 .11
CE 502 178 485 263 188 965
Villous width (lm) Control 201 40 192 38 129 299 20.3  10.6 .06
CE 222 39 221 54 132 346
Villous height: width ratio Control 2.85 0.61 2.78 0.97 1.70 3.98 0.50  0.26 .05
CE 2.35 1.05 2.10 1.19 0.77 7.31
IELs per 100 enterocytes Control 8.57 3.03 8.71 5.30 2.35 13.1 0.13  0.15a .39
CE 10.7 5.80 9.46 7.22 1.22 30.1
Goblet cells per 100 enterocytes Control 4.41 2.27 4.15 3.74 1.22 8.57 0.08  0.20a .72
CE 4.43 2.92 4.11 3.36 0.00 14.1
Mononuclear cells per 10,000 lm2 Control 140.7 12.7 138.9 18.2 118.8 168.5 10.5  8.4 .21
CE 151.3 30.5 147.3 48.5 100.1 218.4
Eosinophils per 10,000 lm2 Control 0.15 0.29 0.00 0.07 0.00 1.05 0.83  0.33 .012
CE 0.98 1.02 0.84 0.83 0.00 7.53
Neutrophils per 10,000 lm2 Control 0.07 0.17 0.00 0.00 0.00 0.60 0.01  0.04 .87
CE 0.08 0.20 0.00 0.00 0.00 0.98
CD3+ cells per 10,000 lm2 Control 19.3 7.18 19.0 9.35 6.70 37.6 0.31  0.25a .21
CE 31.8 24.2 23.5 23.9 4.3 123.2
IgA+ cells per 10,000 lm2 Control 36.0 16.3 30.2 19.5 14.0 84.1 0.09  0.25a .76
CE 39.0 27.2 31.5 30.0 5.8 126.4
SEM, standard error of the mean; IQR, interquartile range; CE, chronic enteropathy; IEL, intraepithelial lymphocyte. The estimated
overall difference compares CE with control data.
aEstimated overall difference ( SEM) is on a logarithmic scale.
Table 1. Histopathological lesion scores at presentation.
Variable Group Mean SD Median IQR Min Max Estimated Odds Ratio (95% CI) P Value
Villous stunting Control 0.80 0.64 1.0 0.63 0 2 3.56 (1.43–8.89) .007
CE 1.43 0.90 1.5 1.5 0 3
IELs Control 0.04 0.13 0 0 0 0.5 5.89 (0.69–50.1) .07
CE 0.18 0.37 0 0 0 2.0
Epithelial injury Control 0.32 0.34 0.5 0.5 0 1 0.46 (0.10–2.10) .33
CE 0.26 0.36 0 0.5 0 1.5
Crypt distension Control 0 0 0 0 0 0 NA NA
CE 0.14 0.43 0 0 0 2
Lacteal dilatation Control 0.02 0.09 0 0 0 0.5 1.11 (0.12–10.4) .92
CE 0.04 0.21 0 0 0 1.5
Mucosal fibrosis Control 0.54 0.61 0.5 1 0 1.5 2.39 (0.50–11.4) .27
CE 0.81 0.68 0.75 1.5 0 3
Mononuclear cells Control 0.59 0.45 0.5 1 0 1.5 0.80 (0.27–2.36) .68
CE 0.52 0.56 0.5 1 0 2.5
Eosinophils Control 0 0 0 0 0 0 NA NA
CE 0.11 0.36 0 0 0 2
Neutrophils Control 0.07 0.18 0 0 0 0.5 1.04 (0.28–3.90) .95
CE 0.07 0.18 0 0 0 0.5
Overall WSAVA score Control 2.38 1.09 2.25 1.5 0.5 5.0 1.17  0.47a .015
CE 3.55 1.66 3.50 2 0 8.5
SD, standard deviation; IQR, interquartile range; CI, confidence interval; CE, chronic enteropathy; IEL, intraepithelial lymphocyte;
NA, not applicable: statistical tests unreliable because all values in the control group were 0. The estimated odds ratio compares CE
with control data.
aA linear effects model was used to analyze data for overall WSAVA score, for which the corresponding metric of difference is the
“estimated overall difference  standard error of the mean” rather than an odds ratio.
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decrease from weeks 0 to 6 (P = .01), with an esti-
mated odds ratio of 0.45 (95% CI, 0.23–0.85;
Fig 3A). All of the other variables showed no
significant differences between visits (Supporting
Information).
The mean density of eosinophils in the lamina
propria decreased from weeks 0 to 6 (P = .02) by
0.26  0.11 per 10,000 lm2 (Fig 3B). Similarly, the
mean density of mononuclear cells in the lamina pro-
pria decreased between visits (P = .04) by 7.77  3.69
per 10,000 lm2 (Fig 3B). However, the mean density
of neutrophils in the lamina propria showed no change
with time (mean  SD, 0.08  0.20 [week 0] versus
0.06  0.19 [week 6] per 10,000 lm2; P = .54), and
when specific populations of mononuclear cells were
examined by immunohistochemical staining, there were
no differences in mean density of either CD3+ cells
(P = .27) or IgA+ cells (P = .52; Fig 3C). Similarly,
mean numbers of IELs (P = .06) and goblet cells
(P = .42) per 100 enterocytes, and villous height
(P = .76), width (P = .17) and height: width ratio
(P = .61), all showed no significant change between
visits (Supporting Information). The number of IELs
per 100 enterocytes increased in 9/20 dogs and
decreased in 11/20 dogs, prompting us to view the
near-significant result for this variable with caution.
A number of ultrastructural lesions also showed
improvement with dietary treatment. Of the qualitative
variables, the mitochondrial lesion score decreased
from weeks 0 to 6 (P = .03), with an estimated odds
ratio of scores of >0 over this time of 0.33 (95% CI,
0.13–0.88; Fig 4A). In contrast, neither cytoplasmic
vacuolation (P = .07) nor microvillar vesiculation
(P = .43) scores showed any significant overall differ-
ence between visits. Nevertheless, 4/5 dogs showed a
decrease in cytoplasmic vacuolation score, but the
comparison between visits was not significant, suggest-
ing the possibility of a type II error in the analysis of
this variable (Supporting Information). Of the quanti-
tative variables, mean intermicrovillar space decreased
from weeks 0 to 6 (P = .005) by 31.7  11.1 nm
(Fig 4B,C). By comparison, mean microvillous height
increased from weeks 0 to 6 (P = .02) by
Table 3. Ultrastructural data at presentation.
Variable Group Mean SD Median IQR Min Max
Estimated Odds
Ratio (95% CI)
Estimated Overall
Difference ( SEM) P Value
Mitochondrial
lesions
Control 0.17 0.49 0 0 0 3 24.2 (4.34–135) .0006
CE 0.84 1.12 0 2 0 3
Microvillar
vesiculation
Control 0.07 0.36 0 0 0 3 3.69 (0.0013–10,440) .48
CE 0.27 0.82 0 0 0 3
Cytoplasmic
vacuolation
Control 0.11 0.36 0 0 0 2 31.3 (4.57–214.6) .0002
CE 0.82 1.09 0 2 0 3
Microvillous
height (lm)
Control 1.81 0.46 1.77 0.66 0.13 4.17 0.00  0.20 1.00
CE 1.82 0.67 1.70 0.88 0.29 3.98
Microvillous
width (nm)
Control 93.9 20.3 90.0 30.0 10.0 150.0 8.43  5.11 .10
CE 102.4 19.4 100.0 20.0 10.0 170.0
Intermicrovillar
space (nm)
Control 26.9 30.6 20.0 20.0 3.0 380 41.3  13.9 .007
CE 68.2 112.4 40.0 60.0 10.0 1,320
Tight junction
width (nm)
Control 10.5 3.70 9.0 4.0 0 34.0 2.87  1.46 .49
CE 13.4 14.5 10.0 3.0 5.0 201
SEM, standard error of the mean; IQR, interquartile range; CE, chronic enteropathy; IEL, intraepithelial lymphocyte. The estimated
odds ratio (for qualitative data) and estimated overall difference (for quantitative data), respectively, compare CE with control data.
A
B
Fig 1. Ultrastructural lesions in dogs with diet-responsive
chronic enteropathy. Part (A) shows a transmission electron
micrograph of several enterocytes within an endoscopic duodenal
biopsy from a healthy Beagle dog, showing no signs of mitochon-
drial cristeolysis, cytoplasmic vacuolation, or microvillar vesicula-
tion (Bar = 2 lm). By contrast, the left-hand panel in part (B)
illustrates extensive cytoplasmic vacuolation (black arrow) and
mitochondrial swelling and cristeolysis (white arrow), whereas
the right-hand panel shows increased intermicrovillar spacing
(black arrow), in an endoscopic biopsy harvested from a dog
with chronic enteropathy before dietary treatment (Bar = 1 lm).
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0.39  0.17 lm (Fig 4B,C). In contrast to these vari-
ables, neither microvillous width (P = .59) nor tight
junction width (P = .11) showed any significant change
from weeks 0 to 6 (Supporting Information).
Discussion
To the authors’ knowledge, this is the first study to
characterize in parallel the functional, histopathologi-
cal, immunohistochemical, and ultrastructural duode-
nal lesions associated with diet-responsive CE. A
number of lesions at both the light and electron micro-
scopic level were observed, some of which resolved
with a 6-week period of dietary treatment and others
of which persisted. In our assessment of the biopsies,
we complemented the WSAVA scoring system with a
comprehensive panel of morphometric measurements,
but also developed a novel scoring system for ultra-
structural lesions that may be applied in future studies
of this nature. In common with other studies, a sex
predisposition was not apparent in our cases,14,18–20
and their average age was similar to that of the previ-
ously published work.7,8,14,18–21 Bias introduced by
owners or clinicians in determining which dogs to
recruit into this study precluded definitive breed com-
parisons between cases and the general hospital popu-
lation, but Labrador Retrievers, Staffordshire Bull
Terriers, and Boxers were more common in the study
cohort, consistent with their apparent predisposition to
CE in previous studies.7,8,14,18,20–22
Clinical signs of the study dogs generally were simi-
lar to those reported in the literature,7,8,13,15,18,22,23 but
we were surprised to observe melena in 3 dogs, a sign
that usually is associated with more severe disease pre-
disposing to ulceration. Furthermore, although the
median CCECAI of 6.5 suggested the presence of
moderate disease, values ranged up to 15, demonstrat-
ing that diet-responsive CE may be severe in its mani-
festations in certain dogs and underlining the fact that
such patients should not be necessarily denied an ini-
tial dietary trial before antibiotic and immunosuppres-
sive drugs are considered.
A
B
Fig 2. Clinical findings in dogs with chronic enteropathy during a 6-week period of dietary treatment. Data from the 20 study dogs are
shown at presentation (week 0) and 2 weeks and 6 weeks after starting a hypoallergenic diet. Each panel shows a dot plot, with mea-
surements from individual dogs joined by a line to highlight changes, and an associated box-and-whisker plot showing summary data
with overlain individual data points. The boxes show the respective 25th and 75th percentiles, the horizontal lines median values, and
the whiskers, the lowest and highest data points still within 1.5 times the interquartile range of the respective lower and upper quartiles;
a single outlying value is represented by means of an asterisk. All P values  .05 are shown under the respective plots, whereas the num-
bers of observations from individual dogs concordant with the prevailing changes in mean values (increase/decrease) are shown in paren-
theses. (Not all dogs had all measurements taken at every visit.) Part (A) shows an increase in mean body weight and decrease in mean
canine chronic enteropathy clinical activity index (CCECAI) and serum C-reactive protein (CRP) concentration from weeks 0 to 2.
Intestinal permeability measured by the urinary lactulose/rhamnose (L/R) ratio showed no overall change (P = .86), whereas mean intes-
tinal absorptive capacity measured by the urinary xylose/3-O-methylglucose ratio increased from weeks 2 to 6 (B).
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Although the WSAVA scoring system represents an
important advance in the histopathological assessment
of intestinal biopsies, superseding a number of dispa-
rate grading schemes reported in the older litera-
ture,13,14,18,19,21,22,24 it has not been a panacea for the
historical problem of inconsistency of lesion identifica-
tion and grading among different pathologists. Factors
such as tissue processing25 and quality of biopsies17
have a major impact on lesion interpretation, even
when using the WSAVA template. Furthermore, the
WSAVA scoring system does not currently incorporate
an assessment of epithelial goblet cells, which may play
an important role in the pathogenesis of certain forms
of CE,3,26 and has not been validated as a means of
quantitating overall lesion severity, being designed pri-
marily as a pictorial template. To address these short-
comings, all endoscopic procedures were undertaken
according to a standard operating protocol adhering
to best practices to ensure optimal biopsy quality; all
tissue processing was carried out by the same, experi-
enced laboratory; all of the biopsies were rigorously
examined by the senior author (OAG) to eliminate
interobserver variability; and all of the biopsies were
subject to additional morphometric assessments. These
included villous height and width to gauge villous
atrophy, numbers of intraepithelial lymphocytes and
A
C
B
Fig 3. Histological and immunohistochemical observations in dogs with chronic enteropathy before and after a 6-week period of die-
tary treatment. Data from the 20 study dogs are shown at presentation (week 0) and 6 weeks after starting a hypoallergenic diet. Each
panel shows a dot plot, with measurements from individual dogs joined by a line to highlight changes, and—for quantitative variables—
an associated box-and-whisker plot showing summary data with overlain individual data points; red symbols represent overall mean val-
ues per visit. All P values are shown under the respective plots, whereas the numbers of observations from individual dogs concordant
with the prevailing changes in mean values (increase/decrease) are shown in parentheses when P  .10. While mononuclear cell score
showed a significant decrease from weeks 0 to 6 (A), all of the other qualitative variables showed no significant change with time. Mean
lamina propria areal densities of both eosinophils and mononuclear cells decreased between visits (B), but neither CD3+ nor IgA+ areal
density showed significant change with time (C). Examples of CD3 and IgA staining from a dog with chronic enteropathy before dietary
treatment are shown (940 objective magnification). (See Figure 2 legend for explanation of boxes and whiskers.)
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goblet cells to gauge epithelial inflammation and
response to injury, and density of mononuclear cells,
eosinophils, and neutrophils to gauge lamina propria
inflammation. For the purposes of qualitative analysis
of lesion severity, we assigned scores of 0 for normal
tissue and 1, 2, and 3 for mild, moderate, and marked
lesions, respectively. Future efforts to validate the
WSAVA scoring system as a measure of overall lesion
severity should consider the merits of differentially
weighting individual criteria. An additional variable
that may confound the interpretation of results is the
potentially multifocal nature of duodenal lesions.
However, we obtained at least 10 biopsies in a stan-
dardized manner from each dog and the process of
choosing villi for assessment was randomized and
consistent.
At the time of presentation, the clinical cases had
more severe mean villous stunting and higher overall
WSAVA scores than the control dogs. Furthermore,
the cases had a lower mean villous height : width ratio,
corroborating the impression of villous stunting, and
a higher mean density of eosinophils in the lamina
propria. The lack of a difference in the qualitative
eosinophil score likely reflects the insensitivity of visual
assessment as a means to detect subtle differences in
numbers of a minority population of cells within the
lamina propria. Indeed, the estimated overall difference
in eosinophil density between cases and controls was
only approximately 1 cell per 100,000 lm2, calling into
question whether this statistical difference was actually
of clinical relevance. Nevertheless, both partial villous
atrophy and an increased number of lamina propria
eosinophils have been associated with intestinal inflam-
mation. The former is thought to be a consequence of
accelerated epithelial proliferation associated with an
increase in the crypt proliferative compartment and a
decrease in the villous absorptive compartment,27 and
the latter a consequence of a hypersensitivity response
to luminal antigens, presumably in this case predomi-
nantly of dietary origin.28–30
As well as demonstrating differences at the level of
the light microscope, our case and control groups
showed striking differences in both qualitative and
quantitative ultrastructural variables. Although elec-
tron microscopy is not a mainstream diagnostic tool in
medicine, it remains an important imaging modality
for the diagnosis of microvillous inclusion disease31
and certain nephropathies in humans,32,33 and ciliary
dyskinesia in the dog.34,35 Moreover, it is a robust
research tool to examine the ultrastructure of the cell.
Ultrastructural assessment of intestinal epithelial injury
generally involves examination of mitochondrial size
and integrity; cytoplasmic vacuolation; microvillous
abundance, height, diameter, and vesiculation; and
tight junction integrity.36 We developed a novel ultra-
structural scoring and measurement protocol that
incorporates all of these observations. Occurring as a
consequence of cellular insults of an inflammatory
nature, lesions in the CE dogs included mitochondrial
cristeolysis, reflecting a process of mitochondrial injury
beginning with the ingress of ions and water that
ultimately leads to uncoupling of oxidative phosphory-
lation37,38; cytoplasmic vacuolation, reflecting the
accumulation of ions and water in injury-induced vesi-
cles39,40; increased space between microvilli, reflecting
the shedding and loss of microvilli41; and increased
tight junction width, reflecting the disruption of junc-
tional integrity and expansion of the intercellular
space.42,43
An important caveat to the conclusions derived
from both the light and electron microscopic studies
was the lack of breed-matching of the cases and
controls, reflecting the challenges of sourcing healthy
control dogs in veterinary clinical research in general.
Laboratory Beagles do not represent an ideal control
group, both because they are known to be associated
with intrinsic differences in enteric bacterial popula-
tions, intestinal permeability, and mucosal cytokine
expression patterns from other breeds,44,45 and because
they live in an exposed, kennel environment, receiving
a standard canine chow, rather than the home environ-
A
C
B
Fig 4. Ultrastructural observations in dogs with chronic enter-
opathy before and after a 6-week period of dietary treatment.
Unfilled symbols represent mean values for 5 adjacent entero-
cytes for each of 5 longitudinally orientated villi per dog. Owing
to the large volume of data collected in these analyses, measure-
ments were made on a random sample of 5 of the 20 study
dogs. Red symbols represent overall mean values per dog, joined
by a line between the time of presentation (week 0) and 6 weeks
after starting a hypoallergenic diet to highlight changes. All P
values are shown under the respective plots, whereas the num-
bers of observations from individual dogs concordant with the
prevailing change in mean values (increase/decrease) are shown
in parentheses. Mitochondrial lesion score decreased significantly
from weeks 0 to 6 (A), whereas mean intermicrovillar space
decreased and mean microvillous height increased between visits
(B). Part (C) shows an example of the repair of brush border
lesions with dietary treatment: the left-hand panel illustrates
mild-to-moderate microvillous atrophy and increased space
between adjacent microvilli, whereas the right-hand panel illus-
trates resolution of these lesions with dietary treatment
(Bar = 1 lm).
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ment of most pet dogs in which various diets may be
offered. Furthermore, fewer Beagles than cases were
available and they were genetically more homoge-
neous, compromising the generality of the comparison.
In addition, the biopsies were collected postmortem,
which could have influenced their size or quality, thus
introducing an additional confounding variable. How-
ever, every effort was made to recapitulate the ante-
mortem biopsy technique and the biopsies from
Beagles appeared not to be larger in size or better
quality compared with those from clinical cases. The
problem is further compounded by the various meth-
ods used by different authors to assess morphometric
variables, making comparisons among studies chal-
lenging. For example, whereas the lamina propria
density of mononuclear cells in our control group was
similar to results derived from various breeds other
than Beagles in studies adopting the same measure-
ment protocol as ours,21,46,47 it differed from results
cited in alternative studies.19,48 Similarly, the lamina
propria density of eosinophils in our control group
was concordant with values cited in 1 study,19 but was
lower than values cited in 2 other studies, even though
they adopted the same measurement protocol as
ours.21,47 Nevertheless, the eosinophil density in our
cases was also lower than values generally cited in the
literature,21,49 suggesting that the difference in eosino-
phil counts between the groups was not attributable
simply to an anomaly of the control dogs in this study.
The issue of a suboptimal control group was circum-
vented in the examination of responses to treatment,
because every case acted as its own control in this part
of the study.
Provision of a hydrolyzed protein diet (a so-called
“hypoallergenic” diet) is a recognized treatment strat-
egy for canine CE.50 Hydrolysis of the protein during
the manufacturing process is thought to generate
polypeptides of a size that are unlikely to stimulate
the immune system. A proportion of dogs with CE
will show full clinical remission in response to dietary
treatment alone.51,52 All of the dogs in this study
were rapidly diet-responsive, as demonstrated by a
striking decrease in mean CCECAI from weeks 0 to
2, with a decrease in individual values in all of the
dogs by the end of the study. Allenspach et al also
showed resolution of clinical signs within 2 weeks of
dietary treatment in dogs with diet-responsive CE,14
suggesting that dietary trials need not be continued
for longer than 2 weeks before alternative diets or
additional treatments are considered. In addition,
there was an increase in mean body weight from
weeks 0 to 6, with an increase in individual results in
12 of the 20 dogs, and a decrease in mean serum
CRP concentration from weeks 0 to 2, with a
decrease in individual results in 12 of 14 dogs in
which CRP was measured. However, only 1 of 55
serum CRP assays yielded a concentration above the
upper reference limit. This observation was at odds
with data from 3 studies of IBD, which all suggested
that increased serum CRP concentrations were com-
mon in dogs with CE.53–55 We surmise that the differ-
ence between these studies and ours was the more
inflammatory nature of the disease in the former, in
which all dogs had failed dietary and antibiotic treat-
ment and required immunosuppressive treatment for
clinical remission. A more recent study of both diet-
responsive and steroid-responsive CE yielded data
more concordant with ours, only 7 of 33 dogs having
serum CRP concentrations above the upper limit of
the reference interval.14 Similarly, many human
patients with IBD have normal serum CRP concen-
trations.56,57 Despite these differences between studies,
serum concentrations of CRP significantly decreased
within the reference interval with treatment in all of
them. Moreover, a recent examination of the biologi-
cal variability in CRP in apparently healthy dogs
suggested that sequential results from a given animal
to determine trends may be more informative than
absolute concentrations.16
Measurements of intestinal permeability and absorp-
tive capacity proved to be unhelpful in the assessment
of the cases in this study, showing no significant
changes from weeks 0 to 6. This observation accords
with the findings of Allenspach et al, who were unable
to demonstrate differences in urinary L/R, X/G, or
sucrose to methylglucose ratios before and after the
treatment in dogs with both diet-responsive and ste-
roid-responsive CE,58 but contrasts with the findings
of several other studies demonstrating higher perme-
ability in dogs with CE of various etiologies.59–62 Sev-
eral potential explanations can be offered to account
for this disparity, including differences in measurement
protocol. For example, voided urine samples were col-
lected using a bowl rather than a metabolism cage in
our study and that of Allenspach et al to ensure that
the test was clinically practical, introducing inherent
inaccuracies if urination was incomplete or part of the
sample was lost during the process of collection. A
blood test for intestinal permeability and function has
been developed in the dog to facilitate sample collec-
tion,63 but was unavailable to us in this study. Another
difference among the various studies lies in the severity
of the disease in the dogs recruited. Permeability
changes may be more likely in dogs requiring immuno-
suppressive treatment, or in those with protein-losing
enteropathy.61,62
A number of histopathological observations were
made after the initiation of dietary treatment in this
study. There was a significant decrease in mean lamina
propria mononuclear cell score. Quantitative variables
also showed a difference, with a significant decrease in
mean lamina propria eosinophil and mononuclear cell
densities, the latter supporting the change in the
corresponding qualitative score. Although the clinical
relevance of relatively small changes in lamina propria
cell densities remains unclear, eosinophils, lymphocytes,
and plasma cells all are potential mediators of intestinal
injury.64 The decrease in numbers of eosinophils recon-
ciled with the higher density of these cells at presenta-
tion and was compatible with amelioration of a
hypersensitivity response to food antigens, whereas the
decrease in mononuclear cells was compatible with gen-
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eral amelioration of mucosal inflammation. Interest-
ingly, these observations were at odds with recent stud-
ies that showed no significant changes in total
lymphocyte counts and histopathological scores of duo-
denal biopsies from dogs with CE (including both diet-
responsive and steroid-responsive disease) after periods
of treatment ranging from 4 to 15 weeks.13,15,65 How-
ever, this study was likely to be more powerful than the
previous study of diet-responsive enteropathy, examin-
ing 20 rather than 10 cases,15 and it applied a compre-
hensive qualitative and quantitative approach to the
analysis of biopsies, being the first to apply the WSA-
VA scoring system to a serial examination of intestinal
biopsies from dogs with CE. Nevertheless, not all dogs
showed changes in these variables that were concordant
with those of the prevailing mean changes, and several
of the examined variables showed no overall difference.
Examples of the latter were lamina propria densities of
CD3+ and IgA+ cells, which remained unchanged
despite the decrease in numbers of mononuclear cells.
We therefore surmised that neither T cells nor IgA-
producing B cells and plasma cells were among the
mononuclear cells showing a response to treatment. A
previous study of duodenal lamina propria CD3+ T
cells in dogs with both diet-responsive and steroid-
responsive disease similarly showed no change with the
inception of treatment.15 Additional studies would be
required to distinguish the responsive populations of
cells within the mononuclear fraction, which could
include macrophages or B cells and plasma cells
producing IgM, IgG, or IgE.
Of particular note in this study was the striking
change in certain ultrastructural variables after the initi-
ation of dietary treatment, including a decrease in the
mean mitochondrial lesion score and intermicrovillar
space, and an increase in the mean microvillous height.
The mitochondrion is a sensitive sentinel of enterocyte
injury, suggesting that the diet had a positive impact on
epithelial cell health.38 These observations also sug-
gested that there was resolution of damage to the brush
border, which serves a number of important digestive,
absorptive, and antimicrobial functions.66,67 Ultrastruc-
tural lesions of the enterocyte have been documented in
a variety of inflammatory enteropathies in humans,
including celiac disease and IBD.41,68–70 This is the first
time that such lesions have been assessed in diet-respon-
sive CE of dogs before and after dietary treatment,
although parallels can be drawn to similar lesions in glu-
ten-sensitive enteropathy in Irish Setters,71 suggesting
that they represent a common pathological end-point of
intestinal inflammation attributable to a variety of dif-
ferent etiologies. Early work assessing the intestinal
mucosa of children with celiac disease indicated that
striking recovery of ultrastructural lesions may occur
with dietary treatment, despite the persistence of lesions
at the light microscopic level.68 This observation corre-
lated with clinical remission and underlines the impor-
tant contribution of the brush border to global
intestinal health, offering a potential explanation of the
findings of previous studies of CE in the dog in which
clinical remission occurred despite persistence of duode-
nal lesions at the light microscopic level. Ultrastructural
lesions also appear to offer a sensitive window on
impending disease, occurring before the observation of
histological lesions in celiac disease.72 Taken together,
the ultrastructural findings reported here are consistent
with findings in the literature on human inflammatory
enteropathies and emphasize some important limita-
tions of light microscopy as a tool for the examination
of the diseased intestine in the dog.
In conclusion, we documented a number of histolog-
ical and ultrastructural lesions in diet-responsive CE in
the dog and identified a significant, albeit subtle,
decrease in lamina propria densities of eosinophils and
mononuclear cells with dietary treatment. Further-
more, dietary treatment was associated with recovery
of enterocyte mitochondrial and brush border health,
documenting for the first time the resolution of key
ultrastructural lesions with clinical remission of dis-
ease. As such, these data support the increasingly held
view that architectural changes are at least as impor-
tant as conventional measures of inflammation in the
pathological assessment of CE and add credence to the
notion that the principal benefit of intestinal biopsies
in dogs with chronic gastrointestinal signs is to rule
out infiltrative, ulcerative, and fungal disease rather
than to catalog the type and number of lamina propria
leukocytes.
Footnotes
a Purina Veterinary Diets HA Hypoallergenic Canine Formula
b Canine C-Reactive Protein ELISA Kit, BD BiosCEnces, San
Jose, CA
c Leica DFC300FX camera attached to Leica DM4000 micro-
scope, Leica Microsystems, Milton Keynes, UK
d Leica QWin V3.4.0 image analysis software, Leica Microsys-
tems, Milton Keynes, UK
e Jeol Jem 100 Electron Microscope, Jeol, Welwyn Garden City,
UK with an ES500W Erlangshen Model 782 camera system,
Gatan, Abingdon, UK
f Data were analyzed by the “stats”, “lme4”, and “multcomp”
packages in R 2.11.0 (Vienna, Austria) except for those for the
qualitative variables “villous stunting”, “mucosal fibrosis”, and
“lamina propria mononuclear cells”, which were analyzed by
the GLIMMIX procedure in SAS version 9.1 for PCs (SAS
Institute Inc, Cary, NC).
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